arrow
Return

Adding a nicotine blocking agent to cigarette tapering

delete2004-07-01
delete4
PRE
AI
P
Peter Gariti *
A
Arthur I. Alterman
K
Kevin G. Lynch
K
Kyle M. Kampman
T
Thomas Whittingham
DOI:10.1016/j.jsat.2004.03.005delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
A non-pharmacologic nicotine-blocking agent (Accu Drop; AD) was preliminarily tested in combination with cigarette tapering and brief counseling (C) in a random assignment, double-blind, placebo controlled, 6-week smoking cessation study (n=60). It was hypothesized that the AD&C group would have higher rates of treatment completion and smoking abstinence than the placebo drop group plus counseling (PD&C). The participants were 37 women and 23 men averaging 24 cigarettes per day along with high Fagerstrom nicotine dependence scores (FTQsimilar to7) and high plasma cotinine levels (>250ng/ml). There were no significant differences between groups for withdrawal scores, treatment completion (55%), or average number of sessions attended. Point prevalence followup evaluations were obtained 1 week, 1 month, and 6 months post projected treatment completion. Biochemically confirmed abstinence rates at followups did not differ between treatment groups (AD&C=10%, 13%, 10% vs. PD&C=3%, 10%, 13%). There is not enough evidence to suggest a Stage II trial. (C) 2004 Elsevier Inc. All rights reserved.
Keywords:
nicotine fading
cigarette tapering
Accu Drop
smoking cessation
motivational interviewing

Journal

Journal of Substance Abuse Treatment cover
Journal of Substance Abuse Treatment
IF:
4
Papers:
3.7K
Citations:
7.6K

Organization

No organization information available